Cleared Traditional

K832489 - CONVEEN DRIP COLLECTOR/NET PANTS (FDA 510(k) Clearance)

Class I Gastroenterology & Urology device.

K832489 · Telcam Medical Devices, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1983
Decision
47d
Days
Class 1
Risk

K832489 is an FDA 510(k) clearance for the CONVEEN DRIP COLLECTOR/NET PANTS. Classified as Garment, Protective, For Incontinence (product code EYQ), Class I - General Controls.

Submitted by Telcam Medical Devices, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 12, 1983 after a review of 47 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5920 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Telcam Medical Devices, Inc. devices

Submission Details

510(k) Number K832489 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 27, 1983
Decision Date September 12, 1983
Days to Decision 47 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 130d · This submission: 47d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code EYQ Garment, Protective, For Incontinence
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 876.5920
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.